Clinical Trial
doi: 10.5935/0305-7518.19690022.
Treatment of moderately severe erythema nodosum leprosum with thalidomide--a double-blind controlled trial
- PMID: 4893253
- DOI: 10.5935/0305-7518.19690022
Item in Clipboard
Clinical Trial
Treatment of moderately severe erythema nodosum leprosum with thalidomide--a double-blind controlled trial
Lepr Rev.
1969 Apr.
No abstract available
Similar articles
-
An internally-controlled double blind trial of thalidomide in severe erythema nodosum leprosum.Lepr Rev. 1971 Mar;42(1):26-42. doi: 10.5935/0305-7518.19710004. Lepr Rev. 1971. PMID: 4338720 Clinical Trial. No abstract available.
-
Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum.Clin Pharmacol Ther. 1970 Jul-Aug;11(4):481-7. doi: 10.1002/cpt1970114481. Clin Pharmacol Ther. 1970. PMID: 4913866 Clinical Trial. No abstract available.
-
Letter: Thalidomide in erythema nodosum leprosum.Lancet. 1973 Nov 24;2(7839):1201-2. doi: 10.1016/s0140-6736(73)92959-0. Lancet. 1973. PMID: 4127565 No abstract available.
-
Thalidomide in erythema nodosum leprosum.DICP. 1990 May;24(5):482-3. DICP. 1990. PMID: 2188435 Review. No abstract available.
-
The role of thalidomide in the management of erythema nodosum leprosum.Lepr Rev. 2007 Sep;78(3):197-215. Lepr Rev. 2007. PMID: 18035771 Review.
Cited by
-
Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase.Br J Pharmacol. 2009 Dec;158(7):1720-34. doi: 10.1111/j.1476-5381.2009.00446.x. Br J Pharmacol. 2009. PMID: 19912234 Free PMC article.
-
Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.Drug Saf. 1992 Mar-Apr;7(2):116-34. doi: 10.2165/00002018-199207020-00004. Drug Saf. 1992. PMID: 1605898 Review.
-
Interventions for erythema nodosum leprosum.Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD006949. doi: 10.1002/14651858.CD006949.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588412 Free PMC article.
-
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors.Oncotarget. 2014 Sep 30;5(18):8161-72. doi: 10.18632/oncotarget.2415. Oncotarget. 2014. PMID: 25327558 Free PMC article. Clinical Trial.
-
Thalidomide: an antineoplastic agent.Curr Oncol Rep. 2002 Jan;4(1):56-62. doi: 10.1007/s11912-002-0048-5. Curr Oncol Rep. 2002. PMID: 11734114 Review.